The gut microbiota associated with prediabetes and treatment naïve type 2 diabetes patients

Sobi will distribute the asset in its territories. Credit: Swedish Orphan Biovitrum AB. Swedish Orphan Biovitrum (Sobi) and Enable Injections have entered a global agreement

Share this article Zephyr AI’s current target areas are in oncology and cardiometabolic diseases. Image credit: Shutterstock/NicoElNino. The startup funding landscape for deep technology companies

Plus, news about An­nex­on, Passkey Ther­a­peu­tics, XO­MA Roy­al­ty and Twist Bio­science: Macro­Gen­ics sells breast can­cer drug rights for up to $75 mil­lion: The com­pa­ny is